» Articles » PMID: 35905941

Generation of Pro-and Anti-inflammatory Mediators After Acetaminophen Overdose in Surviving and Non-surviving Patients

Overview
Journal Toxicol Lett
Publisher Elsevier
Specialty Toxicology
Date 2022 Jul 29
PMID 35905941
Authors
Affiliations
Soon will be listed here.
Abstract

Acetaminophen (APAP) overdose causes liver injury in animals and humans. Although well-studied in animals, limited longitudinal data exist on cytokine release after APAP overdose in patients. The purpose of this study was to quantify concentrations of cytokines in APAP overdose patients to determine if early cytokine or complement measurements can distinguish between surviving and non-surviving patients. Plasma was obtained from healthy controls, APAP overdose patients with no increase in liver transaminases, and surviving and non-surviving APAP overdose patients with severe liver injury. Interleukin-10 (IL-10), and CC chemokine ligand-2 (CCL2, MCP-1) were substantially elevated in surviving and non-surviving patients, whereas IL-6 and CXC chemokine ligand-8 (CXCL8, IL-8) had early elevations in a subset of patients only with liver injury. Day 1 IL-10 and IL-6 levels, and Day 2 CCL2, levels correlated positively with survival. There was no significant increase in IL-1α, IL-1β or TNF-α in any patient during the first week after APAP. Monitoring cytokines such as CCL2 may be a good indicator of patient prognosis; furthermore, these data indicate the inflammatory response after APAP overdose in patients is not mediated by a second phase of inflammation driven by the inflammasome.

Citing Articles

A dual role of inflammation in acetaminophen-induced liver injury.

Xu L, Wang H Liver Res. 2025; 7(1):9-15.

PMID: 39959696 PMC: 11791818. DOI: 10.1016/j.livres.2023.03.001.


Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease.

Jin D, Zhang M, Shi L, Liu H Int J Neuropsychopharmacol. 2024; 28(1).

PMID: 39223908 PMC: 11781222. DOI: 10.1093/ijnp/pyae038.


The p21 perinecrotic hepatocytes produce the chemokine CXCL14 after a severe acetaminophen overdose promoting hepatocyte injury and delaying regeneration.

Umbaugh D, Nguyen N, Smith S, Ramachandran A, Jaeschke H Toxicology. 2024; 504:153804.

PMID: 38614205 PMC: 11108579. DOI: 10.1016/j.tox.2024.153804.


Toxoplasma gondii IST suppresses inflammatory and apoptotic responses by inhibiting STAT1-mediated signaling in IFN-γ/TNF-α-stimulated hepatocytes.

Seo S, Lee J, Ham D, Shin E Parasites Hosts Dis. 2024; 62(1):30-41.

PMID: 38443768 PMC: 10915271. DOI: 10.3347/PHD.23129.


The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review.

McGill M, Curry S Livers. 2024; 3(4):569-596.

PMID: 38434489 PMC: 10906739. DOI: 10.3390/livers3040039.


References
1.
Williams C, Antoine D, Shaw P, Benson C, Farhood A, Williams D . Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol Appl Pharmacol. 2011; 252(3):289-97. PMC: 3086334. DOI: 10.1016/j.taap.2011.03.001. View

2.
James L, McCullough S, Lamps L, Hinson J . Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 2003; 75(2):458-67. DOI: 10.1093/toxsci/kfg181. View

3.
Antoine D, Williams D, Kipar A, Jenkins R, Regan S, Sathish J . High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci. 2009; 112(2):521-31. DOI: 10.1093/toxsci/kfp235. View

4.
Stutchfield B, Antoine D, MacKinnon A, Gow D, Bain C, Hawley C . CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure. Gastroenterology. 2015; 149(7):1896-1909.e14. PMC: 4672154. DOI: 10.1053/j.gastro.2015.08.053. View

5.
Williams C, Farhood A, Jaeschke H . Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury. Toxicol Appl Pharmacol. 2010; 247(3):169-78. PMC: 2929281. DOI: 10.1016/j.taap.2010.07.004. View